| Product Code: ETC8286685 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Pneumococcal Vaccine Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Pneumococcal Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Pneumococcal Vaccine Market - Industry Life Cycle |
3.4 Mexico Pneumococcal Vaccine Market - Porter's Five Forces |
3.5 Mexico Pneumococcal Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Mexico Pneumococcal Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Mexico Pneumococcal Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Mexico Pneumococcal Vaccine Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.9 Mexico Pneumococcal Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Pneumococcal Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing pneumococcal diseases |
4.2.2 Growing government initiatives to improve healthcare infrastructure and increase vaccination coverage |
4.2.3 Rising incidence of pneumococcal diseases and the need for effective preventive measures |
4.3 Market Restraints |
4.3.1 High cost associated with pneumococcal vaccines and limited access to healthcare services in certain regions |
4.3.2 Challenges in vaccine distribution and reaching remote areas with vaccination programs |
4.3.3 Vaccine hesitancy and misinformation about vaccine safety among the population |
5 Mexico Pneumococcal Vaccine Market Trends |
6 Mexico Pneumococcal Vaccine Market, By Types |
6.1 Mexico Pneumococcal Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Pneumococcal Vaccine Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Mexico Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021- 2031F |
6.1.4 Mexico Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021- 2031F |
6.2 Mexico Pneumococcal Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Mexico Pneumococcal Vaccine Market Revenues & Volume, By Prevnar 13, 2021- 2031F |
6.2.3 Mexico Pneumococcal Vaccine Market Revenues & Volume, By Synflorix, 2021- 2031F |
6.2.4 Mexico Pneumococcal Vaccine Market Revenues & Volume, By Pneumovax 23, 2021- 2031F |
6.2.5 Mexico Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Mexico Pneumococcal Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Mexico Pneumococcal Vaccine Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.3 Mexico Pneumococcal Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.4 Mexico Pneumococcal Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4 Mexico Pneumococcal Vaccine Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Mexico Pneumococcal Vaccine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Mexico Pneumococcal Vaccine Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Mexico Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Mexico Pneumococcal Vaccine Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Mexico Pneumococcal Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021- 2031F |
6.5.3 Mexico Pneumococcal Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021- 2031F |
6.5.4 Mexico Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Mexico Pneumococcal Vaccine Market Import-Export Trade Statistics |
7.1 Mexico Pneumococcal Vaccine Market Export to Major Countries |
7.2 Mexico Pneumococcal Vaccine Market Imports from Major Countries |
8 Mexico Pneumococcal Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates among target population groups |
8.2 Number of healthcare facilities offering pneumococcal vaccination services |
8.3 Rate of adverse events following vaccination reported and managed effectively |
8.4 Percentage of children and elderly population vaccinated against pneumococcal diseases |
8.5 Investment in research and development for the development of more affordable and accessible pneumococcal vaccines |
9 Mexico Pneumococcal Vaccine Market - Opportunity Assessment |
9.1 Mexico Pneumococcal Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Mexico Pneumococcal Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Mexico Pneumococcal Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Mexico Pneumococcal Vaccine Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.5 Mexico Pneumococcal Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Pneumococcal Vaccine Market - Competitive Landscape |
10.1 Mexico Pneumococcal Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Mexico Pneumococcal Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here